EMPULSE: The ‘missing link’ for empagliflozin in heart failure | Adriaan Voors Medicine Matters diabetes 5:21 2 years ago 2 186 Скачать Далее
ACC 22: Results from the EMPULSE Study - Empagliflozin Proves Beneficial for Patients with HF Radcliffe 5:36 2 years ago 1 760 Скачать Далее
RECOVERY Trial - Participant Information Oxford Population Health 2:21 4 years ago 2 589 Скачать Далее
RECOVERY Trial - Randomised Evaluation of COVID-19 Therapy Oxford Population Health 2:14 4 years ago 33 150 Скачать Далее
EMPEROR-Reduced: Empagliflozin benefits in HF patients irrespective of diabetes | Milton Packer Medicine Matters diabetes 6:28 3 years ago 9 721 Скачать Далее
ESC 2022: The EMMY Trial: Empagliflozin in Patients with Acute MI | Prof Harald Sourji Radcliffe 2:56 1 year ago 1 240 Скачать Далее
EMPEROR Preserved: Empagliflozin in heart failure with preserved ejection fraction Cardiology Update 1:33 2 years ago 534 Скачать Далее
EMPEROR PRESERVED trial. Empagliflozin in HFpEF patients. Cardio-Ed 6:41 2 years ago 1 842 Скачать Далее
Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Medical Dialogues 5:10 2 years ago 1 341 Скачать Далее
New Myocardial Infarction Clinical Trial: Empagliflozin for Myocardial Infarction Power Life Sciences 1:16 1 year ago 29 Скачать Далее
ADA 2020: Findings from EMPA-REG OUTCOME trial — Dr Muthiah Vaduganathan Radcliffe 10:30 4 years ago 1 213 Скачать Далее
RECOVERY Trial - Aspirin, Baricitinib and Colchicine Oxford Population Health 11:34 3 years ago 1 634 Скачать Далее
RECOVERY Trial - How to receive informed consent Oxford Population Health 13:09 2 years ago 3 201 Скачать Далее
AHA 2021: EMPATROPISM FE: Effects of Empagliflozin on Iron Metabolism in Non-diabetic HF Patients Radcliffe 2:17 2 years ago 323 Скачать Далее
